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Abstract
Objective
To analyze the relationships between insight, medication adherence, addiction, coping and
social support—components of Illness Management and Recovery (IMR)—as determinants
of clinical, functional and personal recovery in patients with schizophrenia and other severe
mental illnesses. Our rationale lay in the interrelations between these concepts suggested
in a conceptual framework of IMR.
Methods
The cross-sectional design used baseline data of outpatient participants in a randomized
clinical trial on IMR (N = 187). We used structural equation modeling (SEM) to describe
pathways between degrees of insight, medication adherence, addiction, coping and social
support, and degree of clinical, functional and personal recovery. We also explored whether
clinical recovery mediated functional and personal recovery.
Results
Our final model showed that coping was associated with clinical, functional and personal
recovery. Direct associations between coping and functional and personal recovery were
stronger than indirect associations via clinical recovery. Although SEM also showed a signif-
icant but weak direct pathway between social support and functional recovery, there were
no significant pathways either between social support and clinical or personal recovery, or
between insight, medication adherence, addiction and any type of recovery.
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Conclusions
Coping may be a determinant of all three types of recovery, and social support a determinant
of functional recovery. Clinical recovery appears not to be a prerequisite for functional or per-
sonal recovery. While our results also suggest the relevance of improving coping skills and of
enhancing social support, they only partially support the conceptual framework of IMR.
Introduction
In recent years the concept of recovery has become increasingly important, and is generating
interest and optimism among various stakeholders, such as service users, providers and payers
[1]. Treatment success in mental healthcare for people with schizophrenia or other serious and
persistent mental illnesses (SMI) is perceived more and more as progress in terms of the degree
of recovery. However, recovery is a complex and multidimensional concept, and has been
defined in various ways [2–4]. In a typology that is used throughout this paper, three types of
recovery can be differentiated, which should not be considered as mutually exclusive, but as
complementary aspects of recovery [5]. In this typology recovery is regarded as an outcome
and as a cross-sectional reflection of functional status [3]. The first type is clinical or symptom-
atic recovery, which as defined in the present study, concerns the degree of psychiatric symp-
tomatology [6–8]. This does not equate with symptomatic remission, i.e., the absence or a
sustained reduction in symptoms over a certain period and scored below distinct thresholds
[2, 7, 9–11].
The second type is functional recovery, also named objective recovery [12]. While some
authors equate this with functional remission [7, 9], others consider it to be part of clinical
recovery [13–14]. Or they regard cognitive functioning as part of the definition [9, 15–16].
However, in the present study, functional recovery is defined as the degree of vocational and
social functioning, such as acting according to age-appropriate role expectations, the perfor-
mance of daily living tasks without supervision, engagement in social interactions [15], and
the degree of independence with regard to housing [4, 9]. Functional recovery thus concerns
functional outcomes rather than functional capacity [17–19].
The third type of recovery is personal recovery, a term that originated among people with
lived experience of mental illness and also highlights the personal nature of the recovery pro-
cess [20–21]. Sometimes named subjective recovery [12], it includes components such as spiri-
tuality, empowerment, actively accepting the illness, and also finding hope, re-establishing a
positive identity, developing meaning in life, overcoming stigma, taking control of one’s own
life, and having supporting relationships [7]. In a shorter definition, it concerns the extents of
perceived recovery, sense of purpose, and personal agency [12]. To summarize the key ele-
ments of personal recovery, various authors use the acronym CHIME: connectedness; hope
and optimism about the future; identity; meaning in life; and empowerment [22].
One program for promoting recovery is Illness Management and Recovery (IMR), a curric-
ulum-based psychosocial program for people with SMI that is intended to improve various
aspects of illness management and self-management; and also by helping participants to set
and achieve personal goals. Its overall purpose is to foster clinical recovery and to support per-
sonal and functional recovery. The development of IMR was based on an empirical review of
the research literature on teaching illness self-management strategies to people with SMI. In
this review, five empirically supported strategies were distinguished: psychoeducation on SMI
and its treatment, cognitive-behavioral techniques to medication adherence, developing a
relapse prevention plan, enhancing social support by social skills training, and coping skills
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training for controlling persistent symptoms. Those five illness management strategies were
integrated into the IMR program [12, 23]. The theoretical foundation of IMR rests on two
models. The first, the trans-theoretical model, holds that people are more motivated to acquire
new behavior if the types of intervention are adjusted to the stage of change they are in [24–
25]. The second model is the stress-vulnerability model, which holds not only that mental
health problems originate from the interaction between biological vulnerability and sources of
stress in the environment, but also that people differ in their coping ability [12, 26–27].
The aim of our main study, a randomized clinical trial (RCT) on IMR, is to determine the
effectiveness of the IMR program in people with SMI as described in our protocol [28]. The
design is to compare the effects of “IMR + Care as Usual (CAU)” with those of “CAU only” on
illness management constituents and on the three types of recovery mentioned. Measurement
was planned to take place before randomization and at 12 and 18 months after randomization.
Generalized linear mixed models (GLMM) are used to investigate group differences between
the experimental and control conditions over an 18 months period, including a 12 months
treatment period and a 6 months follow-up period.
The working mechanisms of IMR are suggested in a conceptual framework in which better
illness management leads to better clinical recovery, and better clinical recovery leads to more
personal and functional recovery, see S1 Fig [12, 28]. For the present cross-sectional study we
used the data of all 187 people who participated in the baseline measurement of our RCT on
IMR. Aim of this analysis is to seek empirical support for any relationships between the con-
cepts suggested in this conceptual framework, but without the input of the IMR-program. We
used structural equation modeling (SEM) to develop a recovery-path model on the basis of the
direct and indirect associations proposed in this framework. This considers the associations
between various components of illness management and the degree of clinical, functional and
personal recovery. These components of illness management include psychiatric insight,
adherence to medication, substance use, coping and social support, all being important ingre-
dients of the theoretical base of the IMR-training.
We also explored whether clinical recovery does indeed mediate the association between
these constituents of illness management and functional and personal recovery. We hypothe-
sized that while the five illness-management constituents had direct pathways to clinical recov-
ery, they had indirect pathways, via clinical recovery, to functional and personal recovery.
SEM is a convenient statistical method for exploring such direct and indirect relationships for
inferential purposes in a cross-sectional analysis [29–31].
Methods
Study participants
In this study baseline data were used of 187 people who agreed to participate in the Dutch
RCT on IMR [28]. There were four inclusion criteria for this RCT: (1) having severe and per-
sistent mental illness (SMI), such as a psychotic disorder or a schizoaffective disorder with or
without comorbid disorders such as substance abuse and personality disorders; (2) being aged
between 18 and 65; (3) currently at or recently admitted to the outpatient mental health ser-
vices at one of two participating mental healthcare institutions in the Rotterdam area in the
Netherlands; and (4) being willing and able to give written informed consent. There were
three exclusion criteria: (1) having already participated in IMR training; (2) being unable to
give informed consent due to intellectual disabilities; and (3) insufficient knowledge of the
Dutch language. Participants in the study were recruited through clinician referrals for IMR
from one of the 14 participating community mental health teams.
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Data collection
In interviews with participating clients and their clinicians, research assistants collected infor-
mation on social-demographic variables: age, gender, living situation, educational level, native
country, and source of income, and on psychiatric history: length of treatment and number
and length of hospital admissions. This information was later cross-validated in the electronic
client files. During the interviews with clinicians, we collected the diagnoses that had previ-
ously been made by psychiatrists in the community mental health teams on the basis of clinical
interviews: psychotic disorders, mood disorder and/or personality disorder. These were also
cross-validated in the electronic client files. In these interviews with clients and clinicians,
questionnaires were filled out on illness management, clinical, functional and personal
recovery.
This study was conducted in accordance with the Declaration of Helsinki. The RCT was
approved by the medical research ethics committee (MREC) at Erasmus MC Rotterdam
(Netherlands), and accredited by the Dutch Central Committee on Research Involving
Human Subjects (CCMO), and was registered under number NTR 5033 in the Dutch National
Trial Register [28].
Measures
Illness management constituents. Coping was assessed using the client-rated Coping
Self-Efficacy Scale (CSES). As the 26 items of the CSES are rated on a scale of 0–10, total scores
range from 0–260, with higher scores indicating higher self-efficacy for coping with challenges
and threats. The CSES consists of three factors: using problem-focused coping (12 items); stop-
ping unpleasant emotions and thoughts (9 items); and getting support from friends and family
(5 items) [32]. Social support was assessed using the client-rated Multidimensional Scale of
Perceived Social Support (MSPSS), whose 12 items are rated on a scale of 1–7. Total scores
therefore range from 12–84, with higher scores indicating higher perceived social support. The
MSPSS has a three-subscale structure: family, friends, and significant others [33]. Medication
adherence was assessed using the treatment-adherence-subscale of the clinician-rated Service
Engagement Scale (SES). As the four items of this subscale are rated on a scale of 0–3, possible
total scores of the subscale range from 0–12, with higher scores indicating higher medication
adherence. The total SES (14 items) includes four subscales: availability, collaboration, help-
seeking, and treatment adherence [34]. Psychiatric insight was measured using the client-rated
Insight Scale (IS), which captures three dimensions of insight: perceived need for treatment,
awareness of illness, and re-labelling symptoms as pathological [35]. Total scores range from
0–12, with higher scores indicating better insight [36]. Problems with a.) alcohol, or b.) drugs
were assessed using one client-rated item (item 24) from the Addiction Severity Index (ASI).
As the two sub-items of this item are each rated on a scale of 0–4, possible total scores range
from 0–8, with higher scores indicating more substance-related problems. The ASI is a semi-
structured interview designed to provide an overall assessment of the severity of problems in
seven potential problem areas in substance-abusing patients: medical status, employment and
support, drug use, alcohol use, legal status, family/social status, and psychiatric status [37–38].
Clinical recovery. Clinical recovery was operationalized as the score on the client-rated
Brief Symptom Inventory (BSI), whose 53 items are rated on a scale of 0–4. Total mean scores
were used, with higher scores indicating that a client’s symptoms are more severe. The BSI has
nine dimensions: psychoticism, depression, somatization, phobic anxiety, obsessive compul-
siveness, interpersonal sensitivity, anxiety, hostility, and paranoid ideation [39–41]. To reflect
the degree of recovery, the scores were reversed: i.e. a higher total score represents a higher
degree of clinical recovery.
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Functional recovery. Functional recovery was operationalized as the score on the Social
Functioning Scale (SFS), a self-administered questionnaire that consists of 76 items with vary-
ing response formats. A higher score indicates more, or a higher frequency of, competent
behavior. All items are assigned to seven subscales: social engagement/withdrawal; interper-
sonal behavior; pro-social activities; recreation; independence competence; independence per-
formance; employment/occupation. Each subscale score is the sum of all item values of that
subscale, and all subscale values are standardized and normalized to a scaled score
(Mean = 100, SD = 15). The full SFS scale score is computed as the mean of the scaled scores of
the seven subscales [42–43].
Personal recovery. Personal recovery was operationalized as the score on the Mental
Health Recovery Measure (MHRM), whose 30 items are rated on a scale of 0–4. Total mean
scores were used, with higher scores indicating better personal recovery. The questionnaire con-
sists of three subscales: self-empowerment, learning and new potentials, and spirituality [44–47].
Statistical analyses
First, Pearson correlations were computed for the five constituents of illness management we
measured: insight, coping, social support, medication adherence, and problems with alcohol
and drugs; and also for clinical, functional, and personal recovery. Three categories were used
in our interpretation of correlations: weak [0.1, 0.3), moderate [0.3, 0.5) and strong [0.5) [48].
To test our recovery-path model, we used SEM. The major advantages of this analysis are
the ability to identify direct and indirect pathways and corresponding errors and to examine
the associations among multiple independent and dependent variables simultaneously [29].
Our IMR model was tested as follows. First, we fitted the full unconstrained model, i.e. a
model including the full set of illness-management constituents (insight, coping, social support,
alcohol and drug use, and medication adherence) as independent variables, and functional and
personal recovery as dependent variables. Clinical recovery was included as a mediating variable;
see S2 Fig. We estimated the size and significance of all direct and indirect paths. Then, in subse-
quent steps, we removed all paths that did not significantly contribute to the fit of the model.
The fit of the final, simplified, model was then tested against the fit of the full model. A non-sig-
nificant result indicates that the simplified model fits the data as well as the full model does.
To allow for deviation from multivariate normality of the data and missing data-points the
fit of the path-model and of the path coefficients were estimated using the robust maximum
likelihood estimation-method [49–50]. Chi2-tests with Satorra-Bentler correction were used to
compare the fit of the nested models [51]. The fit of the final model was evaluated using the fol-
lowing: Chi2 and p-value (p>.05) and Chi2/df ratio (where a ratio smaller than 1.5 indicates a
good fit); the Comparative Fit Index (CFI) [52] and Tucker-Lewis Index (TLI) [53] (where val-
ues above .95 indicate a good fit); Root Mean Square Error of Approximation (RMSEA) [54]
(where a value lower than.06 indicates a good fit); and Standardized Root Mean Square Resid-
uals (SRMR) [55](where a value lower than.05 indicates a good fit).
As well as using statistical significance of path coefficients, three categories were used in our
interpretation of the strength of the relationships: weak [0.2, 0.5), moderate [0.5, 0.8) or strong
[0.8) [48]. We used SPSS 23.0 for data-management and descriptive analyses [56]. SEM-analy-
ses were performed using MPlus version 7.4 software [57].
Results
Participants’ characteristics
Modal participants were male, living alone, had a secondary educational level, had been born
in the Netherlands, and had a psychotic disorder. The modal length of treatment was more
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than five years, they had been admitted at least three times, had been hospitalized for less than
one year, and had an income from unemployment, invalidity or sickness benefit (see Table 1).
Correlations
Table 2 presents the correlation coefficients of the constituents of illness management, and of
degrees of clinical, functional, and personal recovery. Significant correlations are highlighted.
The correlation of functional and personal recovery was strong. Clinical recovery had a moder-
ate correlation with functional recovery, and a strong correlation with personal recovery. Func-
tional recovery had a strong correlation with coping, a moderate correlation with social support,
a weak negative correlation with medication adherence, and a weak correlation with alcohol and
drug use. Personal recovery had a strong correlation with coping, a moderate correlation with
social support, and a weak negative correlation with insight and medication adherence.
Structural equation modeling
In accordance with the paths we hypothesized, our exploration of the effects consisted of three
pathways: 1. exploration of the direct pathways between illness-management constituents
(coping, social support, psychiatric insight, addiction, treatment adherence) and clinical recov-
ery; 2. exploration of the direct pathways between clinical recovery and functional and per-
sonal recovery; and 3. exploration of the indirect pathways that lie, via clinical recovery,
between the constituents of illness management and functional and personal recovery.
First, we fitted a full, unconstrained model, i.e., a model containing all the paths between
the full set of the specified illness-management components and the recovery variables. A sim-
plified model was then constructed by subsequently removing all paths that did not signifi-
cantly contribute to the fit of the model. The final model fitted the data well: Chi2 = 13.96;
df = 11; Chi2/df = 1.27; p>0.05; CFI = 0.99; TLI = 0.98; RMSEA = 0.038 (90%CI = 0.000–
0.090); SRMR = 0.028. This simplified model consisted of paths between coping, social sup-
port, clinical recovery, and functional and personal recovery. Table 3 shows all the direct and
indirect path coefficients of the simplified model. Significant paths are shown in Fig 1.
Coping was highly significantly, directly and moderately associated with the degree of clini-
cal and personal recovery. Coping was highly significantly, directly and weakly associated with
the degree of functional recovery. Via clinical recovery, coping was found to have significant
indirect pathways to functional and personal recovery. However the direct associations between
coping and functional and personal recovery were much stronger than the indirect associations.
The SEM showed a minor significant direct pathway between social support and functional
recovery; the small path coefficient suggested a weak association. There were no significant
direct or indirect paths between social support and clinical or personal recovery. This was also
the case between insight, medication adherence, addiction and any type of recovery; but this
may have been because scores in these domains showed limited variance.
Discussion
Main findings
This study was cross-sectional in design, with baseline data for 187 clients from an RCT used
to examine pathways between specific IMR components—insight, medication adherence,
addiction, coping and social support—and degree of clinical, functional and personal recovery,
utilizing SEM. We also sought to explore whether clinical recovery mediated functional and
personal recovery. By using baseline data we did not seek to examine the impact of the IMR
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program but empirical support for the associations between the concepts proposed by the con-
ceptual framework of IMR.
We found that coping was directly and strongly associated with personal and functional
recovery; we also found that these associations were moderated only marginally by clinical
Table 1. Participants’ characteristics.
N %
total 187 100%
gender male 99 53%
female 88 47%
living situation
alone 111 59%
with partner/family 48 26%
in institution1 28 15%
education level
primary 69 37%
secondary 79 42%
higher 39 21%
native country
Dutch 136 72%
Western immigrant 16 9%
Non-western immigrant 35 19%
source of income
employment 12 7%
benefit for unemployment,
invalidity/sickness benefit
126 67%
social security benefit 41 22%
no income 6 3%
missing 2 1%
diagnosis2
psychotic disorders 106 57%
mood disorder 61 33%
personality disorder 58 35%
length of treatment
� 5 years 47 25%
> 5 years 139 74%
missing 1 1%
number of admissions
None 48 26%
1–2 69 37%
� 3 70 37%
length of hospitalization
not hospitalized 48 26%
� 1 year 94 50%
> 1 year 45 24%
M SD
Age (years) 44.29 10.38
1 sheltered living or in hospital
2 one person can have had more than one diagnosis
https://doi.org/10.1371/journal.pone.0222378.t001
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recovery. Therefore, coping seems to be more important for the degree of functional and per-
sonal recovery than the level of clinical recovery is. We found a weak direct pathway between
social support and functional recovery. Insight, medication adherence, alcohol and drug use
were not associated with any type of recovery.
As Fig 1 shows, we found partial empirical support for the conceptual framework of IMR–
see S1 Fig—(1) there was a strong, direct pathway between coping–a component of illness man-
agement—and the degree of clinical recovery; and (2) clinical recovery was associated, albeit
marginally, with functional and personal recovery. However, in a divergence from the concep-
tual framework, there were strong, direct associations between coping and the degree of
Table 2. Correlations (and standard errors), mean scores, and standard deviations for constituents of illness management, and for degrees of clinical, functional
and personal recovery.
Functional Personal Clinical Coping Social Insight Medication Alcohol and
Recovery Recovery Recovery Support Adherence Drug Use
Functional Recovery 1.00
Personal Recovery 0.56 (0.06)��� 1.00
Clinical Recovery 0.44 (0.07)��� 0.60 (0.06)��� 1.00
Coping 0.58 (0.06)��� 0.75 (0.05)��� 0.61 (0.06)��� 1.00
Social Support 0.36 (0.07)��� 0.37 (0.07)��� 0.19 (0.07)�� 0.42 (0.07)��� 1.00
Insight -0.11 (0.07) -0.25 (0.07)�� -0.18 (0.07)� -0.34 (0.07)��� -0.03 (.07) 1.00
Medication Adherence -0.22 (0.07)�� -0.16 (0.07)� -0.11 (0.07) -0.25 (0.07)�� -0.05 (.07) 0.14 (.07) 1.00
Alcohol and Drug Use 0.15 (0.07)� 0.00 (0.07) 0.04 (0.07) 0.09 (0.7) 0.15 (.07)� 0.13 (.07) -0.05 (0.07) 1.00
M 105.54 69.70 1.26 134.74 4.90 9.65 10.78 0.47
SD 8.66 20.19 0.85 50.75 1.51 2.88 1.90 1.18
� p<0.05
�� p<0.01
��� p<0.001
https://doi.org/10.1371/journal.pone.0222378.t002
Table 3. Final model: Standardized direct and indirect path coefficients and standard errors for the pathways between coping, social support, clinical recovery and
functional and personal recovery for people with SMI.
Functional Recovery Personal Recovery
Estimate SE Estimate SE
Coping
Direct path 0.418��� 0.077 0.579��� 0.074
Indirect paths
Coping- Clinical Recovery-Functional Recovery and Personal Recovery 0.103� 0.049 0.146�� 0.042
Total 0.521��� 0.059 0.725��� 0.051
Social Support
Direct path 0.151� 0.063 0.083 0.064
Indirect paths
Social Support- Clinical Recovery- Functional Recovery and Personal Recovery -0.012 0.012 -0.016 0.017
Total 0.139� 0.063 0.067 0.066
Clinical Recovery
Direct path 0.161� 0.073 0.229��� 0.065
� p <0.05
�� p<0.01
��� p<0.001
https://doi.org/10.1371/journal.pone.0222378.t003
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functional and personal recovery. Social support—also a component of illness management—
was not associated with clinical recovery, but had a weak direct association with functional
recovery. In another divergence from the conceptual framework, there were no relationships
between the three other constituents of illness management we measured and the degree of clin-
ical recovery [12]. And, in a third divergence from the conceptual framework, clinical recovery
appeared not to be a prerequisite for personal and functional recovery.
Our finding that clinical recovery was not a prerequisite for functional recovery is in line
with the results of earlier studies that reported that functional recovery had occurred in certain
patients despite continuing symptoms [58–60] and with another study that concluded that no
sequential relationship could be suggested between symptomatic remission and functional
remission [61]. In line with our finding of a significant but weak pathway between clinical
recovery and personal recovery, a recent meta-analysis showed that the association between
clinical and personal recovery is small to medium, and that personal recovery was explained
only partly by symptom severity. The same meta-analysis concluded that treatment and out-
come monitoring of patients with schizophrenia spectrum disorders should pay attention sep-
arately to clinical and personal recovery [8].
Our results underscore the clinical relevance of interventions aiming to improve coping
skills as a means of promoting progress in clinical, functional, and personal recovery, such as
those in the IMR-modules “Coping with stress” and “Coping with problems and persistent
symptoms”. And our findings also confirm the relevance of interventions that focus on
improving social support in order to promote progress in functional recovery, the IMR-mod-
ule “Building social support” being one such intervention.
Strengths/Limitations
The strengths of the study include a large sample size, a broad range of measures–including
those addressing the components of recovery–and analyses that comprise a more comprehen-
sive understanding of predictors of recovery.
As, in their view, recovery models and frameworks are founded mainly on qualitative stud-
ies and expert opinion, Slade et al. have indicated an evidence gap [5]. Such a gap might be
bridged by our study, which is based on the conceptual framework of IMR, uses quantitative
data from standardized recovery measures, and aims explicitly to explore the determinants of
clinical, functional and personal recovery.
Fig 1. Final model showing significant standardized path coefficients of illness management constituents, and
clinical, functional, and personal recovery for people with SMI.
https://doi.org/10.1371/journal.pone.0222378.g001
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And although most of our study population consisted of people with psychotic disorders,
our inclusion of patients with other serious mental illnesses contributes to generalizability in
this domain, and also to external validity.
Our study also has various limitations. First, although coping and personal recovery are dif-
ferent theoretical concepts, they may have some overlap. However, the content of most of the
CSES items is different from that of the MHRM items, especially regarding the items of the
two largest subscales of the CSES, (1) Use problem-focused coping and (2) Stop unpleasant
emotions and thoughts. Secondly: due to our use of specific definitions and operationaliza-
tion’s of the three differentiated types of recovery, the generalizability of our results is limited
in concepts of recovery that have been defined otherwise.
The third limitation is our inability to find significant pathways between addiction, medica-
tion adherence or insight and the degree of clinical, personal and functional recovery. This
may have lain in the fact that a majority of the participants in our study had few problems in
these domains and therefore showed only limited variance on the scores.
Fourth, as our analysis was cross-sectional and not longitudinal, we were unable to deter-
mine temporal causality. And as our analysis was led by the directions of the associations sug-
gested in the conceptual frame work of IMR, we did not explore reverse directions of the
associations between the various concepts.
Potential future directions
We have chosen to use total scores of most measures. More specific results could be obtained,
if analyses were repeated using subscales of the illness management constituents and of the
MHRM, but also using other components of personal recovery, such as self-esteem or self-
stigma. Secondly: the generalizability of this type of research on recovery could increase if
there would be more uniformity in definitions and operationalization’s of the different types
of recovery—see introduction. Thirdly: to gain more insight into the impact of addiction, med-
ication adherence and insight on the different types of recovery a research population could be
chosen having more variance on the scores on these domains. Fourth: to be able to determine
temporal causality this study could be repeated with a longitudinal analysis.“
Conclusions
Our results suggest that coping is a determinant of all three types of recovery, and that social
support is a determinant of functional recovery. Clinical recovery appears not to be a prerequi-
site for functional and personal recovery. Our results also suggest the relevance of improving
coping skills for clinical, functional and personal recovery, and of fostering social support for
functional recovery. The conceptual framework of IMR could be only partially supported.
Supporting information
S1 Fig. Conceptual framework for Illness Management and Recovery [12].
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